ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
-22.4%/yr
vs -8.0%/yr prior
5Y CAGR
+0.6%/yr
Recent deceleration
Acceleration
-14.4pp
Decelerating
Percentile
P33
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $668.63M | -53.8% |
| 2025 | $1.45B | +1.9% |
| 2024 | $1.42B | -0.7% |
| 2023 | $1.43B | +130.0% |
| 2022 | $621.38M | -4.4% |
| 2021 | $650.03M | +24.1% |
| 2020 | $523.95M | -73.8% |
| 2019 | $2.00B | +454.6% |
| 2018 | $359.98M | +164.3% |
| 2017 | $-559.56M | - |